Pfenex Expression Technology Prima RNApols PeliCRM197
  • About
    • Leadership & Team
    • Our Heritage
    • Careers
  • Offerings
    • Protein Expression
    • mRNA Manufacturing Solutions
    • CRM197
  • Insights
    • Press Releases
    • Resource Center
  • Work With Us
Comparable Immunogenicity Observed in Peptides Coupled to PeliCRM197 and KLH in a Murine Model

Comparable Immunogenicity Observed in Peptides Coupled to PeliCRM197 and KLH in a Murine Model

by Primrose Bio | Sep 10, 2025 | Case Studies

Anti-IL-4 Conjugate Vaccine Prepared with PeliCRM197 is More Immunogenic than KLH Analog

Anti-IL-4 Conjugate Vaccine Prepared with PeliCRM197 is More Immunogenic than KLH Analog

by Primrose Bio | Sep 9, 2025 | Case Studies

About
Leadership & Team
Our Heritage
Careers

Therapeutic Protein Solutions
Pfenex Expression Technology®
Pfast™ Feasibility Program
PeliCRM197®
Synthetic Biology

Nucleic Acid Therapeutic Solutions
mRNA Manufacturing Solutions
Prima RNApols™
Evaluate Prima RNApols™
Enzymatic Oligonucleotide Synthesis

Insights

Contact

Terms and Conditions

Privacy Policy

EU Online Dispute Resolution

  • Follow
SIGN UP FOR OUR LATEST NEWS